Access Cannulation Trial II
Recruiting now · Not applicable
Conditions studied: Dialysis; Complications, Vascular Access Complication
In brief
This is a pivotal, interventional, prospective, single-arm, open-label, multi-site clinical investigation intended to support FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
Key facts
- Study ID
- NCT05490225
- Run by
- Voyager Biomedical
- People needed
- 100
- Starts
- 2025-04-23
- Expected to finish
- 2027-03-25
- Last updated by the study team
- 2025-10-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Trinity Research Group — Dothan, Alabama, United States (enrolling)
- Apex Research — Riverside, California, United States (enrolling)
- Brigham and Women's Hospital — Boston, Massachusetts, United States (enrolling)
- Northwell Health — Hyde Park, New York, United States (enrolling)
- MUSC Health Orangeburg — Orangeburg, South Carolina, United States (enrolling)
- Cardiothoracic and Vascular Surgeons — Austin, Texas, United States (enrolling)
- Baylor Scott & White — Dallas, Texas, United States (enrolling)
- Fairlawn Surgery Center — Roanoke, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.